Jinhang Guo , Tiantian Wei , Jiafa Chen , Ancan Hong , Qiuyue He , Yi Lin , Zhe Ren , Tao Qin
{"title":"堇菜多糖的结构表征及免疫活性评价","authors":"Jinhang Guo , Tiantian Wei , Jiafa Chen , Ancan Hong , Qiuyue He , Yi Lin , Zhe Ren , Tao Qin","doi":"10.1016/j.ijpharm.2025.125689","DOIUrl":null,"url":null,"abstract":"<div><div>This study investigated the structure of <em>Viola phillipica</em> polysaccharide (VPP) and its effect as an immune adjuvant for the Newcastle disease vaccine (ND Vaccine). The results showed that VPP comprised of the galacturonic acid, galactose, rhamnose, arabinose with the molar ratio of 36.20: 23.41: 19.72: 11.54 and a molecular weight (Mw) of 1080 kDa. Additionally, the composition of VPP was assessed via FT-IR, methylation, AFM and SEM analyses, indicating that the backbone of the VPP was consisted of T-Ara (f), T-Gal (p), 4-Gal (p)-UA, and T-Rha (p) linkages. Furthermore, VPP was used as an immune adjuvant in combination with ND vaccine in chickens. Remarkable enhancements were observed in the thymus, spleen, and bursa indices of the chickens, the serum levels of ND antibodies and the expression of IL-4 and IFN-γ cytokines, thereby fostering the proliferation of T and B lymphocytes within the spleen. Notably, histopathological analysis indicated that the VPP groups showed increased lymphoid follicles and splenic nodules, as well as greater splenic red pulp density and bursa of Fabricius area. In summary, these findings suggest that VPP could serve as an adjuvant to enhance the immunogenicity of NDV.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"678 ","pages":"Article 125689"},"PeriodicalIF":5.3000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Structural characterization and immune activity evaluation of polysaccharide purified from Viola phillipica\",\"authors\":\"Jinhang Guo , Tiantian Wei , Jiafa Chen , Ancan Hong , Qiuyue He , Yi Lin , Zhe Ren , Tao Qin\",\"doi\":\"10.1016/j.ijpharm.2025.125689\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>This study investigated the structure of <em>Viola phillipica</em> polysaccharide (VPP) and its effect as an immune adjuvant for the Newcastle disease vaccine (ND Vaccine). The results showed that VPP comprised of the galacturonic acid, galactose, rhamnose, arabinose with the molar ratio of 36.20: 23.41: 19.72: 11.54 and a molecular weight (Mw) of 1080 kDa. Additionally, the composition of VPP was assessed via FT-IR, methylation, AFM and SEM analyses, indicating that the backbone of the VPP was consisted of T-Ara (f), T-Gal (p), 4-Gal (p)-UA, and T-Rha (p) linkages. Furthermore, VPP was used as an immune adjuvant in combination with ND vaccine in chickens. Remarkable enhancements were observed in the thymus, spleen, and bursa indices of the chickens, the serum levels of ND antibodies and the expression of IL-4 and IFN-γ cytokines, thereby fostering the proliferation of T and B lymphocytes within the spleen. Notably, histopathological analysis indicated that the VPP groups showed increased lymphoid follicles and splenic nodules, as well as greater splenic red pulp density and bursa of Fabricius area. In summary, these findings suggest that VPP could serve as an adjuvant to enhance the immunogenicity of NDV.</div></div>\",\"PeriodicalId\":14187,\"journal\":{\"name\":\"International Journal of Pharmaceutics\",\"volume\":\"678 \",\"pages\":\"Article 125689\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-05-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0378517325005265\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378517325005265","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Structural characterization and immune activity evaluation of polysaccharide purified from Viola phillipica
This study investigated the structure of Viola phillipica polysaccharide (VPP) and its effect as an immune adjuvant for the Newcastle disease vaccine (ND Vaccine). The results showed that VPP comprised of the galacturonic acid, galactose, rhamnose, arabinose with the molar ratio of 36.20: 23.41: 19.72: 11.54 and a molecular weight (Mw) of 1080 kDa. Additionally, the composition of VPP was assessed via FT-IR, methylation, AFM and SEM analyses, indicating that the backbone of the VPP was consisted of T-Ara (f), T-Gal (p), 4-Gal (p)-UA, and T-Rha (p) linkages. Furthermore, VPP was used as an immune adjuvant in combination with ND vaccine in chickens. Remarkable enhancements were observed in the thymus, spleen, and bursa indices of the chickens, the serum levels of ND antibodies and the expression of IL-4 and IFN-γ cytokines, thereby fostering the proliferation of T and B lymphocytes within the spleen. Notably, histopathological analysis indicated that the VPP groups showed increased lymphoid follicles and splenic nodules, as well as greater splenic red pulp density and bursa of Fabricius area. In summary, these findings suggest that VPP could serve as an adjuvant to enhance the immunogenicity of NDV.
期刊介绍:
The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.